"En nuestro consultorio trabajamos de forma integrada para diagnosticar y tratar a personas con enfermedades o desórdenes en su sistema inmunológico. Nuestro diferencial es la interdisciplina. Un paciente con más de una patología, será evaluado en forma conjunta por los diferentes especialistas del equipo, logrando un enfoque más holístico."

During the past decade, Inmunología BA conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Inmunología BA" are "Colitis, Ulcerative" (1 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "Inmunología BA" in a lesser frequency.

Most popular intervention types in "Inmunología BA" are "Biological" (2 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Golimumab" (2 trials), "Guselkumab" (2 trials), "JNJ-78934804" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Inmunología BA" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Inmunología BA". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Inmunología BA, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Inmunología BA, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".